Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough, K Kashani… - Nephrology dialysis …, 2014 - academic.oup.com
Background Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …
被引用次数：281 相关文章

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

E Hoste, PA McCullough, K Kashani… - NEPHROLOGY …, 2014 - biblio.ugent.be
Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of metalloproteinases
(TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two recently discovered …

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.

EA Hoste, PA McCullough, K Kashani… - … : Official Publication of …, 2014 - europepmc.org
Background Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …
[PDF] semanticscholar.org

[PDF][PDF] Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough, K Kashani… - Nephrol Dial …, 2014 - pdfs.semanticscholar.org
Background. Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …
[PDF] scienceopen.com

[PDF][PDF] Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough, K Kashani… - Nephrol Dial …, 2014 - scienceopen.com
Background. Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …

[引用][C] Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough, K Kashani… - Nephrology Dialysis …, 2014 - cir.nii.ac.jp

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.

EAJ Hoste, PA McCullough, K Kashani… - Nephrology Dialysis …, 2014 - search.ebscohost.com
Background Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …
[PDF] core.ac.uk

[PDF][PDF] Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough, K Kashani, LS Chawla… - core.ac.uk
Background. Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …
[PDF] academia.edu

[PDF][PDF] Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough, K Kashani… - Nephrol Dial …, 2014 - academia.edu
Background. Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

EAJ Hoste, PA McCullough… - Nephrology …, 2014 - hsrc.himmelfarb.gwu.edu
Background Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of
metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP) 7 are two …